‒ anti cd44 apc vio779 (Miltenyi Biotec)
Structured Review
‒ Anti Cd44 Apc Vio779, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 108 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+apc/Granzyme+B+Antibody%2C+anti-human%2Fmouse%2Frat%2C+REAfinity/pm42098128-440-54-58
Average 95 stars, based on 108 article reviews
Images
Related Articles
Incubation:Article Title: Balancing stromal-induced complexity in 3D ovarian cancer models through heterotypic co-culture with fibroblasts or architected micro-scaffolds. Article Snippet: .. Cancer 179 ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS cells were incubated for 20 minutes at 4 °C with the following monoclonal antibodies: ESA (CD326)-PE 180 (Miltenyi Biotec, MACS, clone HEA-125, cat. no. 130-113-826, 1:50), Article Title: Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer. Article Snippet: .. Primary antibodies in concentrations according to the manufacturer’s instructions were added: CD326-PE (EpCAM, #130-093-440, Miltenyi Biotec), CD324-APC (E-cadherin, #130-111-993, Miltenyi Biotec), Article Title: Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains Article Snippet: .. Cells were incubated with the following monoclonal antibodies: anti-ESA (CD326)-PE (Miltenyi Biotec, MACS, clone HEA-125, cat. no. 130-113-826, 1:50), Bioprocessing:Article Title: Balancing stromal-induced complexity in 3D ovarian cancer models through heterotypic co-culture with fibroblasts or architected micro-scaffolds. Article Snippet: .. Cancer 179 ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS cells were incubated for 20 minutes at 4 °C with the following monoclonal antibodies: ESA (CD326)-PE 180 (Miltenyi Biotec, MACS, clone HEA-125, cat. no. 130-113-826, 1:50), Article Title: Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains Article Snippet: .. Cells were incubated with the following monoclonal antibodies: anti-ESA (CD326)-PE (Miltenyi Biotec, MACS, clone HEA-125, cat. no. 130-113-826, 1:50), Magnetic Cell Separation:Article Title: Balancing stromal-induced complexity in 3D ovarian cancer models through heterotypic co-culture with fibroblasts or architected micro-scaffolds. Article Snippet: .. Cancer 179 ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS cells were incubated for 20 minutes at 4 °C with the following monoclonal antibodies: ESA (CD326)-PE 180 (Miltenyi Biotec, MACS, clone HEA-125, cat. no. 130-113-826, 1:50), Article Title: Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains Article Snippet: .. Cells were incubated with the following monoclonal antibodies: anti-ESA (CD326)-PE (Miltenyi Biotec, MACS, clone HEA-125, cat. no. 130-113-826, 1:50), Control:Article Title: Vitamin B6 Pathway Maintains Glioblastoma Cell Survival in 3D Spheroid Cultures. Article Snippet: .. The cell pellets were resuspended and transferred equally into four eppendorf tubes and then mock or control, CD133-PE (Miltenyi Biotec, Bergisch Gladbach, Germany, 130-113-108) and/or Article Title: Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy Article Snippet: Intracellular flow cytometry as performed using Miltenyi Biotec fixation buffer and permeabilization buffer according to the manufacture protocol. .. The following antibodies were used: CD4-FITC, mouse (IgG2bκ, Miltenyi Biotec), CD8-APC-VIO770 APC (REA734, Miltenyi Biotec), CD11b-PE (REA592, Miltenyi Biotec), Ly6c-APC (REA796, Miltenyi Biotec), Ly6g-FITC (REA526, Miltenyi Biotec), CD3-VioBlue (BW264/56, Miltenyi Biotec), CD45 APC (REA737, Miltenyi Biotec), Ly6A-PE (REA422, Miltenyi Biotec), Article Title: Vitamin B6 Pathway Maintains Glioblastoma Cell Survival in 3D Spheroid Cultures Article Snippet: .. The cell pellets were resuspended and transferred equally into four eppendorf tubes and then mock or control, CD133-PE (Miltenyi Biotec, Bergisch Gladbach, Germany, 130-113-108) and/or Flow Cytometry:Article Title: A multipronged Tα1 reset of CD8 + T cell cytotoxicity against breast cancer. Article Snippet: Thymosin α1 (Tα1) is an endogenous thymic peptide that enhances immune competence through activation of T cells, dendritic cells, and innate immune pathways.. However, its direct impact on CD8 T cell–mediated antitumor immunity in breast cancer remains unclear.. In this study, CD8 T cells isolated from peripheral blood of ten healthy donors were cultured under unstimulated, CD3/CD28-stimulated, Tα1-treated, or exhaustion–rescue conditions to evaluate cytotoxic activity against MDA-MB-231 breast cancer cells and CD44 cancer stem-like cells (CD44 CSC-like cells). |
